!!Tibor Harkany - Curriculum Vitae
__Education, academic degrees & docentship (“habilitation”):__
*2005 Docent in Neuropharmacology (Dnr. 3664/2005), Karolinska Institutet, Stockholm, Sweden\\
*1999  PhD in Medical Sciences (summa cum laude). Semmelweis Medical School, Budapest, Hungary (No. 249)\\
*1995 M.Sc. (No. 291/1995), József Attila University, Szeged, Hungary
__Commission of trust:__
*2016 Invited panellist for the H2020 call 'Health, Demographic Change and Wellbeing'\\
*2012, 2015 Panelist for the Life & Health Sciences 2015 Call of Fundação para a Ciência e a Tecnologia (FCT), Lisboa, Portugal.\\
*2015 Panelist for the Neuroscience Board, Hungarian National Research Council (OTKA), Budapest, Hungary.\\
*2014 Mid-term review committee member, Swammerdam Institue for Life Sciences (SILS), University of Amsterdam.\\
*2014- Peer review evaluator for Horizon2020 (advanced ERC grants and health call).\\
*2013 Review board member, “EU Joint Programme – Neurodegenerative Disease Research” (JPND).\\
*2012-2013 Peer review evaluator for FP7 “Ideas” work programme (advanced ERC grants).\\
*2012-2013 KID funding panel member of the Karolinska Institutet (2 funding cycles/year).\\
*2012 Reviewer, Karolinska Institutet-NIH Training Program in Neuroscience.\\
*2009-present Interviewer and evaluator, EMBO long-term and short-term fellowship (>20 grants), on-going.\\
*2008 Review board member of Era-Net NEURON/neurodegenerative diseases for the European Commission (2008).\\
__Recent research grants:__
*2015-2016 Novo Nordisk Foundation (Denmark), principal investigator\\
*2015-2016 Hjärnfonden (Swedish Brain Research Foundation), principal investigator\\
*2015 GW Pharmaceuticals, Histon/Cambridge, United Kingdom, principal investigator\\
*2014-2017 European Union 7th Framework programme, PAINCAGE integrated project, #603191, work package leader\\
*2014 Petrus & Augusta Hedlunds Foundation (Sweden; competitive renewal), co-principal investigator\\
*2014 Novo Nordisk Foundation (Denmark; competitive renewal), principal investigator\\
*2014-2018 Swedish Medical Research Council (Vetenskapsrådet), principal investigator\\
\\ \\
2015 Gordon Research Conference “Cannabinoid Functions in the CNS”, chair (with M. Maccarrone), Il Ciocco Resort, Tuscany, Italy\\
__Editorial boards:__
*2006 Editorial board member, Current Signal Transduction Therapy, Bentham Scientific Publisher\\
*2008 Honorary editorial board member, International Journal of BioSciences and Technology\\
*2008 Scientific review associate, European Journal of Neuroscience\\
*2010 Review editor, Frontiers in Systems Biology\\
*2010 Review editor, Frontiers in Neurodegenerative Diseases\\
*2012 Editorial board member, Dataset Papers in Neuroscience\\
*2013 Editorial board member, Journal of Biochemistry & Biophysics\\
*2015 Field editor (Neuroscience), Amino Acids (Springer)\\
*2016 Editorial board member, Cannabis and Cannabinoid Research (Mary Ann Liebert Inc.)\\
*2016 Editorial board member/assoc. editor, Acta Neuropathologica Communications (Springer)\\
*2011 Guest editor: “Molecular mechanisms of neuronal specification” – European Journal of Neuroscience, Special Issue\\
*2014 Guest editor: “Neurotrophin-endocannabinoid interactions in pain” – European Journal of Neuroscience, Special Issue